首页> 外文OA文献 >Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer.

【2h】

Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer.

机译：血清apE1自身抗体：一种新的潜在肿瘤标志物和非小细胞肺癌化疗疗效的预测因子。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nan Dai; Xiao-Jing Cao; Meng-Xia Li; Yi Qing; Ling Liao; Xian-Feng Lu; Shi-Heng Zhang; Zheng Li; Yu-Xin Yang; Dong Wang;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum tenascin-c as a potential predictive marker of angiogenesis in non-small cell lung cancer. [J] . Ishiwata T, Takahashi K, Shimanuki Y, Anticancer Research: International Journal of Cancer Research and Treatment . 2005,第1B期

机译：血清腱生蛋白-c作为非小细胞肺癌血管生成的潜在预测指标。
2. Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer. [J] . Chiappori AA, Zheng Z, Chen T, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第4期

机译：小细胞肺癌化学治疗功效的潜在预测生物标志物的特征。
3. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. [J] . Nieder C, Andratschke N, Jeremic B, Anticancer Research: International Journal of Cancer Research and Treatment . 2003,第6D期

机译：血清生长因子和肿瘤标志物作为非小细胞肺癌生存预后的比较。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Risk of second primary tumors following treatment of non-small cell lung cancer. [D] . Allen, Pamela K. 2005

机译：非小细胞肺癌治疗后发生第二原发肿瘤的风险。
6. Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer [O] . Nan Dai, Xiao-Jing Cao, Meng-Xia Li, -1

机译：血清自身抗体apE1：一种新的潜在的肿瘤标志物和在非小细胞肺癌化疗疗效预测
7. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients [O] . Shiheng Zhang, Le He, Nan Dai, 2016

机译：血清APE1作为非小细胞肺癌患者的铂化疗的预测标志物
8. Role of CDK5 as a Tumor Suppressor Gene in Non-Small Cell Lung Cancer. [R] . Nelkin, B. D. 2014

机译：CDK5在非小细胞肺癌中作为肿瘤抑制基因的作用。

Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅